BiotechTube

IFN beta-1a + Dexamethasone

Phase 2Terminated
0 watching 0 views this week⚡ Active
44
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Covid19

Conditions

Covid19

Trial Timeline

Aug 23, 2021 → Apr 4, 2022

NCT ID
NCT04860518

About IFN beta-1a + Dexamethasone

IFN beta-1a + Dexamethasone is a phase 2 stage product being developed by Faron Pharmaceuticals for Covid19. The current trial status is terminated. This product is registered under clinical trial identifier NCT04860518. Target conditions include Covid19.

Hype Score Breakdown

Clinical
17
Activity
12
Company
2
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT04860518Phase 2Terminated

Competing Products

20 competing products in Covid19

See all competitors
ProductCompanyStageHype Score
Favipiravir + NitazoxanideStrides PharmaPhase 2
51
Icosapent ethylAmarin CorporationApproved
77
GX-03 + Petrolatum ointmentTurn TherapeuticsPhase 2
44
Cytotoxic T LymphocytesTevogen BioPhase 1
25
DS-5670a + PlaceboDaiichi SankyoPhase 1/2
41
Pegylated Interferon-α2bZydus LifesciencesPhase 2
52
BaricitinibEli LillyPhase 3
77
LY3819253 + Placebo + Remdesivir + VIR-7831 + BRII-196/BRII-198 + AZD7442 + MP0420 + PF-07304814Eli LillyPhase 3
77
bamlanivimabEli LillyApproved
85
1x10^9 vp AZD1222 + 5x10^9 vp AZD1222 + 1x10^10 vp AZD1222AstraZenecaPhase 1
33
Sacubitril / Valsartan Oral Tablet [Entresto] + PlaceboNovartisPhase 1/2
41
PirfenidoneRochePre-clinical
23
Remdesivir + Remdesivir Placebo + CorticosteroidGilead SciencesPhase 3
76
RemdesivirGilead SciencesPre-clinical
22
Remdesivir + Remdesivir Placebo + Aviptadil + Aviptadil Placebo + CorticosteroidGilead SciencesPhase 3
76
anti-COVID19 mRNA-based vaccine (BNT162b2, Comirnaty®, commercialized by Pfizer)PfizerPhase 3
76
Pfizer/BioNTech BNT162b2 mRNA COVID-19 vaccine + CoronaVac COVID-19 vaccine + ChAdOx1 nCoV-19 Covid-19 Vaccine + Ad26.COV2.S COVID-19 VaccinePfizerPre-clinical
22
Tofacitinib 10 mg + PlaceboPfizerPhase 3
76
BNT162b2PfizerPhase 2
51
Anakinra + 0.9% SalineSwedish Orphan BiovitrumPhase 2
51

Other Products from Faron Pharmaceuticals

Interferon beta-1a + PlaceboPhase 3
69
Interferon Beta-1A + PlaceboPhase 2
44
bexmarilimabPhase 1/2
33
Interferon Beta-1APhase 1/2
33
FP-1305 (bexmarilimab)Phase 1/2
33